The Agency and the Member States' competent authorities shall cooperate to continuously develop pharmacovigilance systems capable of achieving high standards of public health protection for all medicinal products, regardless of routes of authorisation, including the use of collaborative approaches, to maximise use of resources available within the Union.
Art. 53 Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…
In forcesince 28 Jan 2019cited 1×
Regulation (EU) 2019/5Lawamends
Changed on 28 Jan 2019
The Agency and the Member States' competent authorities shall cooperate to continuously develop pharmacovigilance systems capable of achieving high standards of public health protection for all medicinal products, regardless of routes of authorisation, including the use of collaborative approaches, to maximise use of resources available within the CommunityUnion.
- 28 Jan 2019 – todayin force
- 31 Mar 2004 – 28 Jan 2019earlier wording